Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Martinez

Showing results (381-390 of 463) with videos related to

Pageof 47
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2016
N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosisThulasi Warrier, Kanishk Kapilashrami, Argyrides Argyrou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2015
First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid TumorsDidier Meulendijks, Wolfgang Jacob, Maria Martinez-Garcia, et al.
Annals of the Rheumatic Diseases|March 10, 2012
Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosisMirko Manetti, Yannick Allanore, Mohamad Saad, et al.
The American Journal of Psychiatry|January 17, 2008
No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric geneticsAlan R Sanders, Jubao Duan, Douglas F Levinson, et al.
Blood|July 15, 2025
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell TherapyLeon D Kaulen, Maria Martinez-Lage, Jeremy S Abramson, et al.
Human Molecular Genetics|November 19, 2010
Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European populationMohamad Saad, Suzanne Lesage, Aude Saint-Pierre, et al.
Neurology|March 17, 2026
Clinical Manifestations of Primary CNS T-Cell Lymphoma: A Retrospective Study of Histopathologic, Molecular, and Neuroimaging FeaturesKatharina Johanna Müller, Philipp Karschnia, Leon D Kaulen, et al.
Investigational New Drugs|January 20, 2018
Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancerAndreas Schneeweiss, Tjoung-Won Park-Simon, Joan Albanell, et al.
Human Genetics|April 11, 2020
CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrixJuan-Manuel Bonet-Fernández, José-Daniel Aroca-Aguilar, Marta Corton, et al.
Blood Advances|February 7, 2019
<i>MYD88</i> L265P mutation and <i>CDKN2A</i> loss are early mutational events in primary central nervous system diffuse large B-cell lymphomasNaema Nayyar, Michael D White, Corey M Gill, et al.
Pageof 47

Showing results (381-390 of 463) with videos related to

Sort By:
Pageof 47
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2016
N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosisThulasi Warrier, Kanishk Kapilashrami, Argyrides Argyrou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2015
First-in-Human Phase I Study of Lumretuzumab, a Glycoengineered Humanized Anti-HER3 Monoclonal Antibody, in Patients with Metastatic or Advanced HER3-Positive Solid TumorsDidier Meulendijks, Wolfgang Jacob, Maria Martinez-Garcia, et al.
Annals of the Rheumatic Diseases|March 10, 2012
Evidence for caveolin-1 as a new susceptibility gene regulating tissue fibrosis in systemic sclerosisMirko Manetti, Yannick Allanore, Mohamad Saad, et al.
The American Journal of Psychiatry|January 17, 2008
No significant association of 14 candidate genes with schizophrenia in a large European ancestry sample: implications for psychiatric geneticsAlan R Sanders, Jubao Duan, Douglas F Levinson, et al.
Blood|July 15, 2025
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell TherapyLeon D Kaulen, Maria Martinez-Lage, Jeremy S Abramson, et al.
Human Molecular Genetics|November 19, 2010
Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European populationMohamad Saad, Suzanne Lesage, Aude Saint-Pierre, et al.
Neurology|March 17, 2026
Clinical Manifestations of Primary CNS T-Cell Lymphoma: A Retrospective Study of Histopathologic, Molecular, and Neuroimaging FeaturesKatharina Johanna Müller, Philipp Karschnia, Leon D Kaulen, et al.
Investigational New Drugs|January 20, 2018
Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancerAndreas Schneeweiss, Tjoung-Won Park-Simon, Joan Albanell, et al.
Human Genetics|April 11, 2020
CPAMD8 loss-of-function underlies non-dominant congenital glaucoma with variable anterior segment dysgenesis and abnormal extracellular matrixJuan-Manuel Bonet-Fernández, José-Daniel Aroca-Aguilar, Marta Corton, et al.
Blood Advances|February 7, 2019
<i>MYD88</i> L265P mutation and <i>CDKN2A</i> loss are early mutational events in primary central nervous system diffuse large B-cell lymphomasNaema Nayyar, Michael D White, Corey M Gill, et al.
Pageof 47